MILLICENT EDGAR: Open Payments
NPI 1437452760 · MITCHELLVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 14 payments from 8 companies in 2025. Trend: 2023 $1,051 · 2024 $1,292 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $426 |
| Hologic Sales and Service, LLC | 3 | $319 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $168 |
| Neurocrine BioSciences, Inc. | 1 | $117 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Novo Nordisk Inc | 1 | $95 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $91 |
Products named: APTIMA, KRYSTEXXA, INGREZZA, Symbravo, Wegovy.
Industry payments across MD — which companies pay providers there.
